Dyne Therapeutics, Inc. · NASDAQ:DYN
Dyne Therapeutics, Inc. shareholders
As of Sep 30, 2026, 259 institutions reported holding Dyne Therapeutics, Inc. Largest: T. Rowe Price, BlackRock and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Dyne Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| T. Rowe Price | 38M | +3.15M | Nov 16, 2026 | |
| BlackRock | 14.5M | +2.07M | Nov 13, 2026 | |
| Vanguard | 13.7M | +2.18M | Nov 13, 2026 | |
| Janus Henderson | 12M | first report | Nov 16, 2026 | |
| Fidelity | 11.1M | −60,631 | Nov 10, 2026 | |
| Wellington | 10.6M | +10.5M | Nov 16, 2026 | |
| State Street | 8.16M | +700K | Nov 12, 2026 | |
| Orbis Allan Gray Ltd | 7.33M | +327K | Nov 16, 2026 | |
| Vestal Point Capital, LP | 6.2M | +2.83M | Nov 16, 2026 | |
| TCG Crossover Management, LLC | 4.62M | no change | Nov 16, 2026 |